User profiles for PAVAN S. UPADHYAYULA

Pavan Upadhyayula

Verified email at ucsd.edu
Cited by 2435

[PDF][PDF] Transferrin receptor is a specific ferroptosis marker

…, ME Stokes, HG Bender, JM Csuka, PS Upadhyayula… - Cell reports, 2020 - cell.com
… Murine glioma tissue samples were provided by Pavan S. Upadhyayula and Liang Lei.
This research was supported by grants to BRS from the National Cancer Institute(R35CA209896 …

Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers

…, AD Harken, CJ Kinslow, PS Upadhyayula… - ACS chemical …, 2020 - ACS Publications
Although radiation is widely used to treat cancers, resistance mechanisms often develop
and involve activation of DNA repair and inhibition of apoptosis. Therefore, compounds that …

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

…, C Dmello, J Zhao, KB Burdett, PS Upadhyayula… - Nature cancer, 2021 - nature.com
Only a subset of recurrent glioblastoma (rGBM) responds to anti-PD-1 immunotherapy.
Previously, we reported enrichment of BRAF/PTPN11 mutations in 30% of rGBM that responded …

[HTML][HTML] Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism

PS Upadhyayula, DM Higgins, A Mela, M Banu… - Nature …, 2023 - nature.com
Ferroptosis is mediated by lipid peroxidation of phospholipids containing polyunsaturated
fatty acyl moieties. Glutathione, the key cellular antioxidant capable of inhibiting lipid …

[HTML][HTML] Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker

AX Chen, RD Gartrell, J Zhao, PS Upadhyayula… - Genome medicine, 2021 - Springer
Background Macrophages are the most common infiltrating immune cells in gliomas and play
a wide variety of pro-tumor and anti-tumor roles. However, the different subpopulations of …

Update on critical care for acute spinal cord injury in the setting of polytrauma

…, JW Rick, H Deng, CP Partow, PS Upadhyayula… - Neurosurgical …, 2017 - thejns.org
Traumatic spinal cord injury (SCI) often occurs in patients with concurrent traumatic injuries
in other body systems. These patients with polytrauma pose unique challenges to clinicians. …

Association of MGMT promoter methylation with survival in low-grade and anaplastic gliomas after alkylating chemotherapy

…, J Grinband, K Taparra, PS Upadhyayula… - JAMA …, 2023 - jamanetwork.com
Importance O 6 -methylguanine-DNA methyltransferase (MGMT[OMIM156569]) promoter
methylation (mMGMT) is predictive of response to alkylating chemotherapy for glioblastomas …

Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial

EF Spinazzi, MG Argenziano, PS Upadhyayula… - The Lancet …, 2022 - thelancet.com
Background Topotecan is cytotoxic to glioma cells but is clinically ineffective because of drug
delivery limitations. Systemic delivery is limited by toxicity and insufficient brain penetrance, …

Focused ultrasound-mediated blood-brain barrier opening increases delivery and efficacy of etoposide for glioblastoma treatment

HJ Wei, PS Upadhyayula, AN Pouliopoulos… - International Journal of …, 2021 - Elsevier
Purpose Glioblastoma (GBM) is a devastating disease. With the current treatment of surgery
followed by chemoradiation, outcomes remain poor, with median survival of only 15 months …

[HTML][HTML] Selective serotonin reuptake inhibitors for treating neurocognitive and neuropsychiatric disorders following traumatic brain injury: an evaluation of current …

JK Yue, JF Burke, PS Upadhyayula, EA Winkler… - Brain sciences, 2017 - mdpi.com
The prevalence of neuropsychiatric disorders following traumatic brain injury (TBI) is 20%–50%,
and disorders of mood and cognition may remain even after recovery of neurologic …